Overview

Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants

Status:
Recruiting

Trial end date:
2021-12-03

Target enrollment:

Participant gender:

Summary

The purpose of this study is to estimate the effect PF-07321332/Ritonavir and Ritonavir on Midazolam (a cytochrome P450 [CYP]3A4 substrate) in Healthy Adult Participants.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Midazolam
Ritonavir